---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-056533"
form_type: "8-K"
ticker: "MDGL"
cik: "0001157601"
company_name: "MADRIGAL PHARMACEUTICALS, INC."
filed_at: "2025-12-11T23:59:59+00:00"
generated_at: "2026-05-16T13:28:04.957332+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Madrigal appoints Rita Thakkar as SVP and Chief Accounting Officer, effective Jan 12, 2026

## Summary
- Rita Thakkar joins as principal accounting officer; Mardi Dier remains CFO and principal financial officer.
- Thakkar previously SVP Global Business Operations at Bristol Myers Squibb and Chief Audit Officer at BMS and Celgene.
- Annual base salary of $450,000 with target bonus of 40% of salary; initial equity grant valued at $1,932,000.
- Equity award composed of 70% time-based RSUs (4-year vest) and 30% stock options (graded vest over 4 years).
- Severance agreement provides 12 months salary and bonus upon qualifying separation, with enhanced benefits on change of control.

## SEC filing metadata
- accession: 0001628280-25-056533
- form_type: 8-K
- ticker: MDGL
- cik: 0001157601
- company_name: MADRIGAL PHARMACEUTICALS, INC.
- filed_at: 2025-12-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157601/000162828025056533/0001628280-25-056533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157601/000162828025056533/mdgl-20251205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-056533
- JSON: https://secwatch.observer/filing/0001628280-25-056533.json
- Plain text: https://secwatch.observer/filing/0001628280-25-056533.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.